Minireviews Open Access
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Hypertens. Aug 23, 2014; 4(3): 25-28
Published online Aug 23, 2014. doi: 10.5494/wjh.v4.i3.25
Influence of periodontitis on abdominal aortic aneurysms
Jun-ichi Suzuki, Department of Advanced Clinical Science and Therapeutics, The University of Tokyo, Tokyo 113-8655, Japan
Norio Aoyama, Department of Periodontology, Tokyo Medical and Dental University, Tokyo 113-8549, Japan
Author contributions: Suzuki J and Aoyama N analyzed the data and wrote the paper.
Supported by Mitsui Life Social Welfare Foundation, Daiwa Security Health Foundation, Mitsui Sumitomo Marine Welfare Foundation, Institute of Geriatric Dentistry Foundation, Institute of St. Luka Life Science Foundation, Health Welfare Foundation, Taiyo Life Welfare Foundation, the 8020 Foundation, Terumo Science Foundation, Pfizer Health Research Foundation, and General Health Promotion Foundation
Correspondence to: Jun-ichi Suzuki, MD, PhD, Department of Advanced Clinical Science and Therapeutics, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan. junichisuzuki-circ@umin.ac.jp
Telephone: +81-3-58009116 Fax: +81-3-58009182
Received: June 26, 2014
Revised: July 15, 2014
Accepted: August 20, 2014
Published online: August 23, 2014

Abstract

Periodontitis is known to be a risk factor for abdominal aortic aneurysm (AAA). However, the influence of periodontitis on AAA development is to be elucidated. This article is to review the relationship between periodontitis and AAA. We focused on the roles of specific periodontopathic bacteria in AAA, matrix metalloproteinases and toll-like receptors in the pathophysiology in the section of experimental analysis. Furthermore, we showed clinical data of periodontitis in patients with AAA. We concluded that periodontal pathogens play a critical role in the AAA development.

Key Words: Periodontitis, Abdominal aortic aneurysm, Periodontopathic bacteria, Matrix metalloproteinases, Toll-like receptors

Core tip: This article is to review the relationship between periodontitis and abdominal aortic aneurysm. We showed experimental and clinical data to demonstrate the relationship. We concluded that the infection of periodontal pathogens is critical in the aneurysm development.



INTRODUCTION

Abdominal aortic aneurysm (AAA) is a common diseases, however, it is life-threatening[1,2]. In AAA development, inflammation enhances a disruption of the lamellar structure of the aortic wall[3]. Pathological examination demonstrated that inflammatory cell infiltration was occasionally observed in human AAA tissue[4,5]. An increased expression of matrix metalloproteinases (MMPs) is also observed in human aneurysm tissue samples[6,7].

Periodontitis is the most common chronic infectious diseases in humans. Pathologically, it is characterized by gingival inflammation and the loss of periodontal support tissue[8]. Periodontopathic bacteria enhance the local immunological inflammation, resulting in the secretion of proinflammatory cytokines and MMPs[9]. This leads to the extracellular matrix destruction of the periodontal tissues[10]. In patients with periodontitis, several inflammatory markers increase[11], meaning that systemic inflammation can be caused by the local periodontal infection.

A strong association between dental and cardiovascular diseases has been demonstrated[12,13]. Especially, periodontal diseases are known to be a significant independent risk factor for cardiovascular disease[14]. Previous studies revealed a deep relationship between periodontal diseases and AAA[15,16]. Clinical investigations demonstrated that some periodontal pathogens accelerated the progression of AAA[17], however, the specific influence of each periodontal bacterium on AAA was not investigated. Recently, we demonstrated the pathophysiolocial and epidemiological relationship between specific periodontal pathogens and AAA using experimental[18-20] and clinical studies[21,22]. This article reviews the association between periodontitis and AAA.

PORPHYROMONAS GINGIVALIS IS HIGHLY AFFECTED IN SYSTEMIC DISEASES

It is reported that more than 700 bacterial species exist in the oral cavity[23]. Some of them are implicated in the oral disease progression[24]. Porphyromonas gingivalis (P. gingivalis) is a periodontopahic bacterium that is highly associated with the chronic periodontitis. It is frequently detected in the disease sites, while it is detected rarely in healthy sites[25]. The presence of P. gingivalis in a periodontal pocket is a predictable factor for periodontal disease progression[26]. Thus, a reduction of P. gingivalis numbers is critical in a resolution of the disease at the affected site[27,28]. Experimental investigation showed that the infection of P. gingivalis induced a local inflammatory response and periodontal bone loss[29]. This bacterium has several virulence factors, including cysteine proteinases (gingipains), lipopolysaccharide, capsule and fimbriae[30]. However, the roles of these virulence factors are still to be elucidated.

EXPERIMENTAL MODELS OF PERIODONTOPATHIC BACTERIA INFECTION AND AAA

Recently, we revealed that P. gingivalis worsened AAA development in experimental murine AAA models. The model showed that P. gingivalis significantly increased the aortic diameter compared to the control mice, while another periodontal bacterium, A. actinomycetemcomitans showed no statistical difference. Immunohistochemically, the CD8- and MOMA2-positive cell numbers of P. gingivalis-infected mice were significantly higher than control animals. We concluded that P. gingivalis could accelerate the progression of experimental AAA[18].

To reveal the pathophysiological mechanism, we focused on MMPs in the animal models. To suppress MMP activity, we used clarithromycin (CAM). We found that CAM administration significantly decreased the P. gingivalis-challenged aortic diameter compared to the mice only injected with P. gingivalis. Histopathologically, the aortic samples harvested from the P. gingivalis-challenged and CAM-treated mice showed less elastic degradation. Furthermore, the plasma levels of MMP-2 in the CAM-treated mice significantly decreased. These findings suggest that MMP-2 is an important factor for developing P. gingivalis-accelerated AAA[19].

Next, we analyzed the role of toll-like receptors (TLRs) because they are key receptors of virulence factors of periodontopathic bacteria. To reveal the mechanism, we used TLR knockout mice on P. gingivalis-accelerated AAA progression. We found that the P. gingivalis-infected TLR-2 knockout mice showed a lower rate of aortic diameter increase compared to the P. gingivalis-infected wild-type mice. However, the aortic diameter of the P. gingivalis-infected TLR-4 knockout mice statistically increased. Immunohistochemically, the expression levels of MMP-2 in the aneurysmal wall from TLR-2 knockout mice were lower than that from wild-type mice. These findings clarified that P. gingivalis accelerated the development of AAA via TLR-2 signaling[20].

CLINICAL OBSERVATION OF PERIODONTITIS IN AAA PATIENTS

Based on the animal studies, we surveyed the periodontal conditions in patients with AAA. Firstly, we studied 12 AAA patients and age and sex-matched 24 patients with non-AAA cardiovascular patients. We examined the patients’ oral condition and the presence of periodontal pathogens, P. gingivalis, A. actinomycetemcomitans and P. intermedia in oral samples. We revealed that the AAA patients had deeper pocket depth in comparison to the non-AAA patients. However, the existence of periodontal bacteria was comparable between the two groups. In this observation, we concluded that periodontitis might further affect aneurysm progression compared to other cardiovascular diseases[21].

Next, we compared the periodontal condition between AAA and arrhythmia patients. We studied 142 patients with tachy-arrhythmia (TA) and 25 patients with AAA. We examined patients’ oral condition and the presence of P. gingivalis, A. actinomycetemcomitans and P. intermedia in the patients’ saliva and subgingival plaque. We also measured serum antibody titers against the pathogens using ELISA. We found that the patients with AAA had fewer remaining teeth and deeper pocket depth in comparison to the TA patients. The existence of each periodontal bacterium in their saliva or subgingival plaque and serum antibody titers was comparable between the two groups. We concluded that periodontitis might have a larger affect on aneurysm progression compared to arrhythmia[22].

In these clinical studies, we showed that periodontitis had progressed further in AAA patients compared to patients with other cardiovascular disease. Our result supports the fact that AAA patients had bad oral and periodontal conditions. However, bacterial existence and serum antibody titers were comparable between the groups. This is because other periodontal pathogens may aggravate AAA. A previous study showed that other periodontopathic bacteria were present in AAA specimens[15]. Furthermore, other studies demonstrated that not only P. gingivalis but also other periodontal bacteria were frequently detected in aortic aneurysmal walls (Table 1)[31,32]. Therefore, observation of other periodontal pathogens should be investigated to reveal the relationship between periodontitis and AAA development.

Table 1 Porphyromonas gingivalis and periodontal bacteria were frequently detected in aortic aneurismal walls.
Ref.Article and yearDetected bacteriaSamplesn
Kurihara et al[15]Eur J Vasc Endovasc Surg 2004P. gingivalis, T. denticola, P. intermedia, C. rectus, T. forsythensis, P. nigrescens and A. actinomycetemcomitansAortic wall and mural thrombus32
Marques da Silva et al[31]J Periodontol 2005A. actinomycetemcomitansAortic wall56
Nakano et al[32]Oral Microbiol Immunol 2009P. gingivalis, T. denticola, A. actinomycetemcomitans, S. mutans and S. sanguinisAortic wall86
Delbosc et al[17]PLoS One 2011P. gingivalisAortic wall16

In conclusion, AAA may be associated with periodontitis and a specific periodontal pathogen may affect the progression of AAA. Further investigation is needed to reveal the detailed pathophysiology in the relationship between AAA and periodontal pathogens.

ACKNOWLEDGMENTS

We thank Dr. Yuichi Izumi, Dr. Mitsuaki Isobe, Dr. Naho Kobayashi, Dr. Tomoya Hanatani, Dr. Norihiko Ashigaki, Dr. Asuka Sekinishi, Dr. Makoto Kaneko, Dr. Yuka Shiheido, Dr. Hiroki Sato, Dr. Atsuhi Akai, Dr. Chisato Takamura, Dr. Masahito Ogawa, Dr. Hirofumi Zempo, Mr. Ryo Watanabe and Ms. Noriko Tamura for their excellent contributions.

Footnotes

P- Reviewer: Carinci F, da Silva Figueredo C S- Editor: Ji FF L- Editor: A E- Editor: Liu SQ

References
1.  Ernst CB. Abdominal aortic aneurysm. N Engl J Med. 1993;328:1167-1172.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 528]  [Cited by in F6Publishing: 536]  [Article Influence: 17.3]  [Reference Citation Analysis (0)]
2.  Alcorn HG, Wolfson SK, Sutton-Tyrrell K, Kuller LH, O’Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1996;16:963-970.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 227]  [Cited by in F6Publishing: 213]  [Article Influence: 7.6]  [Reference Citation Analysis (0)]
3.  Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 362]  [Article Influence: 16.5]  [Reference Citation Analysis (0)]
4.  Bobryshev YV, Lord RS, Pärsson H. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc Surg. 1998;6:240-249.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 50]  [Cited by in F6Publishing: 45]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
5.  Pearce WH, Koch AE. Cellular components and features of immune response in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996;800:175-185.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 55]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
6.  Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15:1145-1151.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 466]  [Cited by in F6Publishing: 484]  [Article Influence: 16.7]  [Reference Citation Analysis (0)]
7.  Davis V, Persidskaia R, Baca-Regen L, Itoh Y, Nagase H, Persidsky Y, Ghorpade A, Baxter BT. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 1998;18:1625-1633.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 185]  [Cited by in F6Publishing: 194]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
8.  Choi BK, Jung JH, Suh HY, Yoo YJ, Cho KS, Chai JK, Kim CK. Activation of matrix metalloproteinase-2 by a novel oral spirochetal species Treponema lecithinolyticum. J Periodontol. 2001;72:1594-1600.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 27]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
9.  Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol. 2005;32 Suppl 6:108-129.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 165]  [Cited by in F6Publishing: 165]  [Article Influence: 8.7]  [Reference Citation Analysis (0)]
10.  Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team. Ann N Y Acad Sci. 1999;878:335-346.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 47]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
11.  Reis C, DA Costa AV, Guimarães JT, Tuna D, Braga AC, Pacheco JJ, Arosa FA, Salazar F, Cardoso EM. Clinical improvement following therapy for periodontitis: Association with a decrease in IL-1 and IL-6. Exp Ther Med. 2014;8:323-327.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesäniemi YA, Syrjälä SL, Jungell PS, Isoluoma M, Hietaniemi K, Jokinen MJ. Association between dental health and acute myocardial infarction. BMJ. 1989;298:779-781.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 661]  [Cited by in F6Publishing: 622]  [Article Influence: 17.8]  [Reference Citation Analysis (0)]
13.  Sakurai K, Wang D, Suzuki J, Umeda M, Nagasawa T, Izumi Y, Ishikawa I, Isobe M. High incidence of actinobacillus actinomycetemcomitans infection in acute coronary syndrome. Int Heart J. 2007;48:663-675.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 42]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
14.  Mendez MV, Scott T, LaMorte W, Vokonas P, Menzoian JO, Garcia R. An association between periodontal disease and peripheral vascular disease. Am J Surg. 1998;176:153-157.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 67]  [Cited by in F6Publishing: 72]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
15.  Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, Ishikawa I. Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2004;28:553-558.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 82]  [Cited by in F6Publishing: 74]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
16.  Paraskevas KI, Mikhailidis DP, Giannoukas AD. Periodontitis and abdominal aortic aneurysms: a random association or a pathogenetic link? Int Angiol. 2009;28:431-433.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Delbosc S, Alsac JM, Journe C, Louedec L, Castier Y, Bonnaure-Mallet M, Ruimy R, Rossignol P, Bouchard P, Michel JB. Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS One. 2011;6:e18679.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Aoyama N, Suzuki J, Wang D, Ogawa M, Kobayashi N, Hanatani T, Takeuchi Y, Izumi Y, Isobe M. Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res. 2011;46:176-183.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 34]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
19.  Aoyama N, Suzuki JI, Ogawa M, Watanabe R, Kobayashi N, Hanatani T, Yoshida A, Ashigaki N, Izumi Y, Isobe M. Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice. J Periodontal Res. 2012;47:463-469.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 20]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
20.  Aoyama N, Suzuki J, Ogawa M, Watanabe R, Kobayashi N, Hanatani T, Ashigaki N, Sekinishi A, Izumi Y, Isobe M. Toll-like receptor-2 plays a fundamental role in periodontal bacteria-accelerated abdominal aortic aneurysms. Circ J. 2013;77:1565-1573.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 29]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
21.  Suzuki J, Aoyama N, Aoki M, Tada Y, Wakayama K, Akazawa H, Shigematsu K, Hoshina K, Izumi Y, Komuro I. High incidence of periodontitis in Japanese patients with abdominal aortic aneurysm. Int Heart J. 2014;55:268-270.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
22.  Suzuki JI, Aoyama N, Aoki M, Tada Y, Wakayama K, Akazawa H, Shigematsu K, Hoshina K, Izumi Y, Komuro I. Incidence of periodontitis in Japanese patients with cardiovascular diseases: a comparison between abdominal aortic aneurysm and arrhythmia. Heart Vessels. 2014;Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
23.  Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43:5721-5732.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1867]  [Cited by in F6Publishing: 1895]  [Article Influence: 99.7]  [Reference Citation Analysis (0)]
24.  Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000. 2006;42:80-87.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 524]  [Cited by in F6Publishing: 518]  [Article Influence: 28.8]  [Reference Citation Analysis (0)]
25.  Yang HW, Huang YF, Chou MY. Occurrence of Porphyromonas gingivalis and Tannerella forsythensis in periodontally diseased and healthy subjects. J Periodontol. 2004;75:1077-1083.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 93]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
26.  van Winkelhoff AJ, Loos BG, van der Reijden WA, van der Velden U. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction. J Clin Periodontol. 2002;29:1023-1028.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 270]  [Cited by in F6Publishing: 286]  [Article Influence: 13.0]  [Reference Citation Analysis (0)]
27.  Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL, Socransky SS. The effect of SRP on the clinical and microbiological parameters of periodontal diseases. J Clin Periodontol. 1997;24:324-334.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 331]  [Cited by in F6Publishing: 346]  [Article Influence: 12.8]  [Reference Citation Analysis (0)]
28.  Fujise O, Hamachi T, Inoue K, Miura M, Maeda K. Microbiological markers for prediction and assessment of treatment outcome following non-surgical periodontal therapy. J Periodontol. 2002;73:1253-1259.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 43]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
29.  Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10:497-506.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 721]  [Cited by in F6Publishing: 769]  [Article Influence: 59.2]  [Reference Citation Analysis (0)]
30.  Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62:1244-1263.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Marques da Silva R, Caugant DA, Lingaas PS, Geiran O, Tronstad L, Olsen I. Detection of Actinobacillus actinomycetemcomitans but not bacteria of the red complex in aortic aneurysms by multiplex polymerase chain reaction. J Periodontol. 2005;76:590-594.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 31]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
32.  Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, Amano A, Ooshima T. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol. 2009;24:64-68.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 139]  [Cited by in F6Publishing: 144]  [Article Influence: 9.6]  [Reference Citation Analysis (0)]